BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-08-20

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-20	Common Stock	M	5000	$12.99	Acquired	51195	Indirect
2014-08-20	Common Stock	S	5000	$70.00	Disposed	46195	Indirect

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-20	Stock Option (right to buy common stock)	$12.99	M	5000	Disposed	2016-05-10	Common Stock (5000)	Indirect

Security	Shares	Ownership
Common Stock	229157	Direct

F1: Transaction made pursuant to a Rule 10b5-1 trading plan executed on February 26, 2013.

F2: The reporting person and his spouse act as trustees for the Bienaime Family Trust.

F3: All shares sold at same price

F4: Original option grant vests 6/48th on November 11, 2006, and 1/48thj on the 11th day of every month thereafter.

F5: Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.